Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Study of CEP-701 in Treatment of Prostate Cancer Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for qualified medical advice, visits or professional assistance by using a real mD. We are not docs. Always confer with your physician about Study of CEP-701 in Treatment of Prostate Cancer conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Study of CEP-701 in Treatment of Prostate Cancer Clinical research trials and Study of CEP-701 in Treatment of Prostate Cancer health trials occur in many of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectivity of new does drugs. The intent of the studies / undertakings is to resolve particular human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to detect remedies for all sorts of conditions, including Study of CEP-701 in Treatment of Prostate Cancer. Study of CEP-701 in Treatment of Prostate Cancer Clinical Trials and other clinical trials permit volunteers to obtain healthcare treatment alternatives before they are available to the masses. Most times the participants undergo professional assistance for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Study of CEP-701 in Treatment of Prostate Cancer clinical trial. Test subjects typically receive the most expert healthcare available for their Study of CEP-701 in Treatment of Prostate Cancer condition. Dangers are a reality, however, and may include more or frequent mD visits, healthcare dangers (perhaps life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with rigid guidelines to protect clinical trials patients.

Home > "S" Clinical Trials Conditions > Study of CEP-701 in Treatment of Prostate Cancer

Study of CEP-701 in Treatment of Prostate Cancer



Study of CEP-701 in Treatment of Prostate Cancer

For Condition: Prostate Cancer
Status: Recruiting
Sponsor(s): Cephalon ,
Synopsis: The purpose of this study is to determine the proportion of patients with a serological prostate specific antigen (PSA) by day 85.
Details: A serological PSA response is defined as a reduction from baseline PSA serum concentration of at least 50%, which is confirmed by a second PSA value 28 or more days later.
Eligibility:
Study Type:  Interventional, Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Male
Protocol Entry Criteria: Inclusion Criteria: - at least 18 yrs of age - diagnosis of adenocarcinoma of the prostate - no detectable metastatic disease as assessed by bone and CT scans - has increasing serum PSA concentrations - life expectancy of at least 3 months - ECOG of 0 or 1 - has been withdrawn from antiandrogen therapy for at least 6 weeks prior to entering screening period Exclusion Criteria: - has asymptomatic disease - has active GI ulceration or bleeding - has been treated with non-hormonal systemic anticancer therapy or has received radiation within 4 weeks of baseline visit - bilirubin >2x ULN or ALT or AST >2xULN or serum creatinine >1.5mg/dL - hemoglobin <9g/dL or platelets below 100,000/uL or ANC below 1500/uL - receiving treatment for HIV with protease inhibitors - has had prior malignancy within past 5 yrs with exception of resected basal or squamous cell carcinomas of the skin - has used investigational drug with previous one month
Total Enrollment: 30

Location and Contact Information:

Johns Hopkins *Recruiting*
Baltimore,  Maryland,  21287
United States
Recruiting Patient  Office 410-955-8964


Additional Information:
Study ID Numbers:  C0701a/203/ON/US; 
Study Start Date: October 2003
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00081601

Other Prostate Cancer Studies:
1. Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain

2. Treatment Decision Intervention for Veterans with Prostate Cancer

3. Treatment with Zometa in patients with breast cancer, multiple myeloma, and prostate cancer with cancer related bone lesions

4. Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

5. Open-label Trial on the Effect of I.V. Zometa 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients with Bone Metastasis

Related Studies:

Other Prostate Cancer Clinical Trials
Other Maryland Clinical Trials
Other Baltimore Clinical Trials

Study of CEP-701 in Treatment of Prostate Cancer
Modify your Search

  Other Prostate Cancer Clinical Trials
  Other Maryland Clinical Trials
  Other Baltimore Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103